Justices Seek Word From Amphastar In Drug Safe Harbor Case
Suggesting it may be interested in reviewing the scope of the Hatch-Waxman Act's safe harbor for drug patents, the U.S. Supreme Court on Tuesday asked Amphastar Pharmaceuticals Inc. to respond to...To view the full article, register now.
Already a subscriber? Click here to view full article